Compile Data Set for Download or QSAR

Found 46 hits with Last Name = 'guha' and Initial = 't'   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kJ/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
Diacylglycerol O-acyltransferase 1 (Homo sapiens (Human))	BDBM50436848 (CHEMBL2403617) Show SMILES CC(C)[C@H](NC(=O)c1ncc(s1)-c1ccc(Nc2nc3ccc(F)cc3s2)cc1)C(O)=O |r| Show InChI InChI=1S/C22H19FN4O3S2/c1-11(2)18(21(29)30)27-19(28)20-24-10-17(31-20)12-3-6-14(7-4-12)25-22-26-15-8-5-13(23)9-16(15)32-22/h3-11,18H,1-2H3,(H,25,26)(H,27,28)(H,29,30)/t18-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	n/a	n/a	10	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Enterprises Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counti...				Eur J Med Chem 65: 337-47 (2013) Article DOI: 10.1016/j.ejmech.2013.05.006 BindingDB Entry DOI: 10.7270/Q2QJ7JPW
					More data for this Ligand-Target Pair
Diacylglycerol O-acyltransferase 1 (Homo sapiens (Human))	BDBM50436846 (CHEMBL2403620) Show SMILES CC(C)[C@H](NC(=O)c1ncc(s1)-c1ccc(NC(=O)Nc2ccccc2Cl)cc1)C(O)=O |r| Show InChI InChI=1S/C22H21ClN4O4S/c1-12(2)18(21(29)30)27-19(28)20-24-11-17(32-20)13-7-9-14(10-8-13)25-22(31)26-16-6-4-3-5-15(16)23/h3-12,18H,1-2H3,(H,27,28)(H,29,30)(H2,25,26,31)/t18-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	16	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Enterprises Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counti...				Eur J Med Chem 65: 337-47 (2013) Article DOI: 10.1016/j.ejmech.2013.05.006 BindingDB Entry DOI: 10.7270/Q2QJ7JPW
					More data for this Ligand-Target Pair
Diacylglycerol O-acyltransferase 1 (Homo sapiens (Human))	BDBM50436845 (CHEMBL2403621) Show SMILES CC(C)[C@H](NC(=O)c1ncc(s1)-c1ccc(NC(=O)Nc2ccc(C)c(C)c2)cc1)C(O)=O |r| Show InChI InChI=1S/C24H26N4O4S/c1-13(2)20(23(30)31)28-21(29)22-25-12-19(33-22)16-6-9-17(10-7-16)26-24(32)27-18-8-5-14(3)15(4)11-18/h5-13,20H,1-4H3,(H,28,29)(H,30,31)(H2,26,27,32)/t20-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	20	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Enterprises Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counti...				Eur J Med Chem 65: 337-47 (2013) Article DOI: 10.1016/j.ejmech.2013.05.006 BindingDB Entry DOI: 10.7270/Q2QJ7JPW
					More data for this Ligand-Target Pair
Diacylglycerol O-acyltransferase 1 (Homo sapiens (Human))	BDBM50436847 (CHEMBL2403619) Show SMILES CC(C)[C@H](NC(=O)c1ncc(s1)-c1ccc(NC(=O)Nc2cccc(c2)C(F)(F)F)cc1)C(O)=O |r| Show InChI InChI=1S/C23H21F3N4O4S/c1-12(2)18(21(32)33)30-19(31)20-27-11-17(35-20)13-6-8-15(9-7-13)28-22(34)29-16-5-3-4-14(10-16)23(24,25)26/h3-12,18H,1-2H3,(H,30,31)(H,32,33)(H2,28,29,34)/t18-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	22	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Enterprises Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counti...				Eur J Med Chem 65: 337-47 (2013) Article DOI: 10.1016/j.ejmech.2013.05.006 BindingDB Entry DOI: 10.7270/Q2QJ7JPW
					More data for this Ligand-Target Pair
Diacylglycerol O-acyltransferase 1 (Homo sapiens (Human))	BDBM50436842 (CHEMBL2403624) Show SMILES CC(C)[C@H](NC(=O)c1ncc(s1)-c1ccc(NC(=O)c2ccc(cc2)C(C)(C)C)cc1)C(O)=O |r| Show InChI InChI=1S/C26H29N3O4S/c1-15(2)21(25(32)33)29-23(31)24-27-14-20(34-24)16-8-12-19(13-9-16)28-22(30)17-6-10-18(11-7-17)26(3,4)5/h6-15,21H,1-5H3,(H,28,30)(H,29,31)(H,32,33)/t21-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	23	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Enterprises Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counti...				Eur J Med Chem 65: 337-47 (2013) Article DOI: 10.1016/j.ejmech.2013.05.006 BindingDB Entry DOI: 10.7270/Q2QJ7JPW
					More data for this Ligand-Target Pair
Diacylglycerol O-acyltransferase 1 (Homo sapiens (Human))	BDBM50436844 (CHEMBL2403622) Show SMILES CC(C)[C@H](NC(=O)c1ncc(s1)-c1ccc(NC(=O)Nc2ccccc2Oc2ccccc2)cc1)C(O)=O |r| Show InChI InChI=1S/C28H26N4O5S/c1-17(2)24(27(34)35)32-25(33)26-29-16-23(38-26)18-12-14-19(15-13-18)30-28(36)31-21-10-6-7-11-22(21)37-20-8-4-3-5-9-20/h3-17,24H,1-2H3,(H,32,33)(H,34,35)(H2,30,31,36)/t24-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	23	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Enterprises Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counti...				Eur J Med Chem 65: 337-47 (2013) Article DOI: 10.1016/j.ejmech.2013.05.006 BindingDB Entry DOI: 10.7270/Q2QJ7JPW
					More data for this Ligand-Target Pair
Diacylglycerol O-acyltransferase 1 (Homo sapiens (Human))	BDBM50386149 (CHEMBL2042351) Show SMILES CC(C)[C@H](NC(=O)c1ccc(cc1)-c1ccc(Nc2nc3ccc(F)cc3s2)cc1)C(O)=O |r| Show InChI InChI=1S/C25H22FN3O3S/c1-14(2)22(24(31)32)29-23(30)17-5-3-15(4-6-17)16-7-10-19(11-8-16)27-25-28-20-12-9-18(26)13-21(20)33-25/h3-14,22H,1-2H3,(H,27,28)(H,29,30)(H,31,32)/t22-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	n/a	n/a	35	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Enterprises Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1				Eur J Med Chem 65: 337-47 (2013) Article DOI: 10.1016/j.ejmech.2013.05.006 BindingDB Entry DOI: 10.7270/Q2QJ7JPW
					More data for this Ligand-Target Pair
Diacylglycerol O-acyltransferase 1 (Homo sapiens (Human))	BDBM50436841 (CHEMBL2403625) Show SMILES CC(C)[C@H](NC(=O)c1ncc(s1)-c1ccc(NC(=O)CCC2CCCCC2)cc1)C(O)=O |r| Show InChI InChI=1S/C24H31N3O4S/c1-15(2)21(24(30)31)27-22(29)23-25-14-19(32-23)17-9-11-18(12-10-17)26-20(28)13-8-16-6-4-3-5-7-16/h9-12,14-16,21H,3-8,13H2,1-2H3,(H,26,28)(H,27,29)(H,30,31)/t21-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	37	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Enterprises Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counti...				Eur J Med Chem 65: 337-47 (2013) Article DOI: 10.1016/j.ejmech.2013.05.006 BindingDB Entry DOI: 10.7270/Q2QJ7JPW
					More data for this Ligand-Target Pair
Diacylglycerol O-acyltransferase 1 (Homo sapiens (Human))	BDBM50436839 (CHEMBL2403627) Show SMILES CCCCc1ccc(nc1)C(=O)Nc1ccc(cc1)-c1cnc(s1)C(=O)N[C@@H](C(C)C)C(O)=O |r| Show InChI InChI=1S/C25H28N4O4S/c1-4-5-6-16-7-12-19(26-13-16)22(30)28-18-10-8-17(9-11-18)20-14-27-24(34-20)23(31)29-21(15(2)3)25(32)33/h7-15,21H,4-6H2,1-3H3,(H,28,30)(H,29,31)(H,32,33)/t21-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	49	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Enterprises Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counti...				Eur J Med Chem 65: 337-47 (2013) Article DOI: 10.1016/j.ejmech.2013.05.006 BindingDB Entry DOI: 10.7270/Q2QJ7JPW
					More data for this Ligand-Target Pair
Diacylglycerol O-acyltransferase 1 (Homo sapiens (Human))	BDBM50436843 (CHEMBL2403623) Show SMILES CC(C)[C@H](NC(=O)c1ncc(s1)-c1ccc(NC(=O)Nc2ccc(Cl)cc2Oc2ccccc2)cc1)C(O)=O |r| Show InChI InChI=1S/C28H25ClN4O5S/c1-16(2)24(27(35)36)33-25(34)26-30-15-23(39-26)17-8-11-19(12-9-17)31-28(37)32-21-13-10-18(29)14-22(21)38-20-6-4-3-5-7-20/h3-16,24H,1-2H3,(H,33,34)(H,35,36)(H2,31,32,37)/t24-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	58	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Enterprises Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counti...				Eur J Med Chem 65: 337-47 (2013) Article DOI: 10.1016/j.ejmech.2013.05.006 BindingDB Entry DOI: 10.7270/Q2QJ7JPW
					More data for this Ligand-Target Pair
Diacylglycerol O-acyltransferase 1 (Homo sapiens (Human))	BDBM50436840 (CHEMBL2403626) Show SMILES CC(C)[C@H](NC(=O)c1ncc(s1)-c1ccc(NC(=O)C2CCC(F)(F)CC2)cc1)C(O)=O |r| Show InChI InChI=1S/C22H25F2N3O4S/c1-12(2)17(21(30)31)27-19(29)20-25-11-16(32-20)13-3-5-15(6-4-13)26-18(28)14-7-9-22(23,24)10-8-14/h3-6,11-12,14,17H,7-10H2,1-2H3,(H,26,28)(H,27,29)(H,30,31)/t17-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	82	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Enterprises Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counti...				Eur J Med Chem 65: 337-47 (2013) Article DOI: 10.1016/j.ejmech.2013.05.006 BindingDB Entry DOI: 10.7270/Q2QJ7JPW
					More data for this Ligand-Target Pair
Diacylglycerol O-acyltransferase 1 (Homo sapiens (Human))	BDBM50436838 (CHEMBL2403628) Show SMILES CC(C)[C@H](NC(=O)c1ncc(s1)-c1ccc(NC(=O)c2ccc(cc2)C(C)(C)C#N)cc1)C(O)=O |r| Show InChI InChI=1S/C26H26N4O4S/c1-15(2)21(25(33)34)30-23(32)24-28-13-20(35-24)16-7-11-19(12-8-16)29-22(31)17-5-9-18(10-6-17)26(3,4)14-27/h5-13,15,21H,1-4H3,(H,29,31)(H,30,32)(H,33,34)/t21-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	97	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Enterprises Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counti...				Eur J Med Chem 65: 337-47 (2013) Article DOI: 10.1016/j.ejmech.2013.05.006 BindingDB Entry DOI: 10.7270/Q2QJ7JPW
					More data for this Ligand-Target Pair
Diacylglycerol O-acyltransferase 1 (Homo sapiens (Human))	BDBM50436837 (CHEMBL2403629) Show SMILES CCC(CC)(C#N)c1ccc(cc1)C(=O)Nc1ccc(cc1)-c1cnc(s1)C(=O)N[C@@H](C(C)C)C(O)=O |r| Show InChI InChI=1S/C28H30N4O4S/c1-5-28(6-2,16-29)20-11-7-19(8-12-20)24(33)31-21-13-9-18(10-14-21)22-15-30-26(37-22)25(34)32-23(17(3)4)27(35)36/h7-15,17,23H,5-6H2,1-4H3,(H,31,33)(H,32,34)(H,35,36)/t23-/m0/s1	PDB UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	101	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Enterprises Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 using [14C]-oleoylCoA/diolein as substrate assessed as formation of [14C]triglyceride after 10 mins by scintillation counti...				Eur J Med Chem 65: 337-47 (2013) Article DOI: 10.1016/j.ejmech.2013.05.006 BindingDB Entry DOI: 10.7270/Q2QJ7JPW
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386129 (CHEMBL2042217) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2ccc(Cl)cc2F)cc1)C(O)=O |r| Show InChI InChI=1S/C22H20ClFN4O5/c1-11(2)19(21(30)31)27-20(29)18-10-17(28-33-18)12-3-6-14(7-4-12)25-22(32)26-16-8-5-13(23)9-15(16)24/h3-11,19H,1-2H3,(H,27,29)(H,30,31)(H2,25,26,32)/t19-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	2.40E+4	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386149 (CHEMBL2042351) Show SMILES CC(C)[C@H](NC(=O)c1ccc(cc1)-c1ccc(Nc2nc3ccc(F)cc3s2)cc1)C(O)=O |r| Show InChI InChI=1S/C25H22FN3O3S/c1-14(2)22(24(31)32)29-23(30)17-5-3-15(4-6-17)16-7-10-19(11-8-16)27-25-28-20-12-9-18(26)13-21(20)33-25/h3-14,22H,1-2H3,(H,27,28)(H,29,30)(H,31,32)/t22-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	n/a	n/a	3.50E+4	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386126 (CHEMBL2042213) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2ccc(C)c(C)c2)cc1)C(O)=O |r| Show InChI InChI=1S/C24H26N4O5/c1-13(2)21(23(30)31)27-22(29)20-12-19(28-33-20)16-6-9-17(10-7-16)25-24(32)26-18-8-5-14(3)15(4)11-18/h5-13,21H,1-4H3,(H,27,29)(H,30,31)(H2,25,26,32)/t21-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	4.40E+4	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386120 (CHEMBL2042201) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2ccccc2Cl)cc1)C(O)=O |r| Show InChI InChI=1S/C22H21ClN4O5/c1-12(2)19(21(29)30)26-20(28)18-11-17(27-32-18)13-7-9-14(10-8-13)24-22(31)25-16-6-4-3-5-15(16)23/h3-12,19H,1-2H3,(H,26,28)(H,29,30)(H2,24,25,31)/t19-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	4.40E+4	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386122 (CHEMBL2042204) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2cccc(Cl)c2)cc1)C(O)=O |r| Show InChI InChI=1S/C22H21ClN4O5/c1-12(2)19(21(29)30)26-20(28)18-11-17(27-32-18)13-6-8-15(9-7-13)24-22(31)25-16-5-3-4-14(23)10-16/h3-12,19H,1-2H3,(H,26,28)(H,29,30)(H2,24,25,31)/t19-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	4.50E+4	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386137 (CHEMBL2042339) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2ccccc2C(F)(F)F)cc1)C(O)=O |r| Show InChI InChI=1S/C23H21F3N4O5/c1-12(2)19(21(32)33)29-20(31)18-11-17(30-35-18)13-7-9-14(10-8-13)27-22(34)28-16-6-4-3-5-15(16)23(24,25)26/h3-12,19H,1-2H3,(H,29,31)(H,32,33)(H2,27,28,34)/t19-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	5.40E+4	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386145 (CHEMBL2042347) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2cc(C)ccc2F)cc1)C(O)=O |r| Show InChI InChI=1S/C23H23FN4O5/c1-12(2)20(22(30)31)27-21(29)19-11-17(28-33-19)14-5-7-15(8-6-14)25-23(32)26-18-10-13(3)4-9-16(18)24/h4-12,20H,1-3H3,(H,27,29)(H,30,31)(H2,25,26,32)/t20-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	5.40E+4	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386136 (CHEMBL2042338) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2cccc(C)c2)cc1)C(O)=O |r| Show InChI InChI=1S/C23H24N4O5/c1-13(2)20(22(29)30)26-21(28)19-12-18(27-32-19)15-7-9-16(10-8-15)24-23(31)25-17-6-4-5-14(3)11-17/h4-13,20H,1-3H3,(H,26,28)(H,29,30)(H2,24,25,31)/t20-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	5.40E+4	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386131 (CHEMBL2042221) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2ccc(F)cc2)cc1)C(O)=O |r| Show InChI InChI=1S/C22H21FN4O5/c1-12(2)19(21(29)30)26-20(28)18-11-17(27-32-18)13-3-7-15(8-4-13)24-22(31)25-16-9-5-14(23)6-10-16/h3-12,19H,1-2H3,(H,26,28)(H,29,30)(H2,24,25,31)/t19-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	6.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386132 (CHEMBL2042223) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2ccc(C)cc2)cc1)C(O)=O |r| Show InChI InChI=1S/C23H24N4O5/c1-13(2)20(22(29)30)26-21(28)19-12-18(27-32-19)15-6-10-17(11-7-15)25-23(31)24-16-8-4-14(3)5-9-16/h4-13,20H,1-3H3,(H,26,28)(H,29,30)(H2,24,25,31)/t20-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	6.10E+4	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386130 (CHEMBL2042219) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2ccc(F)cc2F)cc1)C(O)=O |r| Show InChI InChI=1S/C22H20F2N4O5/c1-11(2)19(21(30)31)27-20(29)18-10-17(28-33-18)12-3-6-14(7-4-12)25-22(32)26-16-8-5-13(23)9-15(16)24/h3-11,19H,1-2H3,(H,27,29)(H,30,31)(H2,25,26,32)/t19-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	6.20E+4	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386133 (CHEMBL2042334) Show SMILES COc1ccc(NC(=O)Nc2ccc(cc2)-c2cc(on2)C(=O)N[C@@H](C(C)C)C(O)=O)cc1 |r| Show InChI InChI=1S/C23H24N4O6/c1-13(2)20(22(29)30)26-21(28)19-12-18(27-33-19)14-4-6-15(7-5-14)24-23(31)25-16-8-10-17(32-3)11-9-16/h4-13,20H,1-3H3,(H,26,28)(H,29,30)(H2,24,25,31)/t20-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	6.40E+4	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386124 (CHEMBL2042210) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2cccc(c2)C(F)(F)F)cc1)C(O)=O |r| Show InChI InChI=1S/C23H21F3N4O5/c1-12(2)19(21(32)33)29-20(31)18-11-17(30-35-18)13-6-8-15(9-7-13)27-22(34)28-16-5-3-4-14(10-16)23(24,25)26/h3-12,19H,1-2H3,(H,29,31)(H,32,33)(H2,27,28,34)/t19-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	6.60E+4	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386148 (CHEMBL2042350) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2cc(F)ccc2C)cc1)C(O)=O |r| Show InChI InChI=1S/C23H23FN4O5/c1-12(2)20(22(30)31)27-21(29)19-11-18(28-33-19)14-5-8-16(9-6-14)25-23(32)26-17-10-15(24)7-4-13(17)3/h4-12,20H,1-3H3,(H,27,29)(H,30,31)(H2,25,26,32)/t20-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	6.90E+4	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386140 (CHEMBL2042342) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2cc(F)cc(F)c2)cc1)C(O)=O |r| Show InChI InChI=1S/C22H20F2N4O5/c1-11(2)19(21(30)31)27-20(29)18-10-17(28-33-18)12-3-5-15(6-4-12)25-22(32)26-16-8-13(23)7-14(24)9-16/h3-11,19H,1-2H3,(H,27,29)(H,30,31)(H2,25,26,32)/t19-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	7.50E+4	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386139 (CHEMBL2042341) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2ccc(F)c(F)c2)cc1)C(O)=O |r| Show InChI InChI=1S/C22H20F2N4O5/c1-11(2)19(21(30)31)27-20(29)18-10-17(28-33-18)12-3-5-13(6-4-12)25-22(32)26-14-7-8-15(23)16(24)9-14/h3-11,19H,1-2H3,(H,27,29)(H,30,31)(H2,25,26,32)/t19-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	7.50E+4	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386138 (CHEMBL2042340) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2ccc(cc2)C(F)(F)F)cc1)C(O)=O |r| Show InChI InChI=1S/C23H21F3N4O5/c1-12(2)19(21(32)33)29-20(31)18-11-17(30-35-18)13-3-7-15(8-4-13)27-22(34)28-16-9-5-14(6-10-16)23(24,25)26/h3-12,19H,1-2H3,(H,29,31)(H,32,33)(H2,27,28,34)/t19-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	8.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386135 (CHEMBL2042337) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2ccccc2C)cc1)C(O)=O |r| Show InChI InChI=1S/C23H24N4O5/c1-13(2)20(22(29)30)26-21(28)19-12-18(27-32-19)15-8-10-16(11-9-15)24-23(31)25-17-7-5-4-6-14(17)3/h4-13,20H,1-3H3,(H,26,28)(H,29,30)(H2,24,25,31)/t20-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	8.40E+4	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386143 (CHEMBL2042345) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2ccc(C)cc2C)cc1)C(O)=O |r| Show InChI InChI=1S/C24H26N4O5/c1-13(2)21(23(30)31)27-22(29)20-12-19(28-33-20)16-6-8-17(9-7-16)25-24(32)26-18-10-5-14(3)11-15(18)4/h5-13,21H,1-4H3,(H,27,29)(H,30,31)(H2,25,26,32)/t21-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	8.50E+4	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386127 (CHEMBL2042215) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2ccc(Cl)cc2Oc2ccccc2)cc1)C(O)=O |r| Show InChI InChI=1S/C28H25ClN4O6/c1-16(2)25(27(35)36)32-26(34)24-15-22(33-39-24)17-8-11-19(12-9-17)30-28(37)31-21-13-10-18(29)14-23(21)38-20-6-4-3-5-7-20/h3-16,25H,1-2H3,(H,32,34)(H,35,36)(H2,30,31,37)/t25-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	8.60E+4	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386147 (CHEMBL2042349) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2ccc(F)cc2C)cc1)C(O)=O |r| Show InChI InChI=1S/C23H23FN4O5/c1-12(2)20(22(30)31)27-21(29)19-11-18(28-33-19)14-4-7-16(8-5-14)25-23(32)26-17-9-6-15(24)10-13(17)3/h4-12,20H,1-3H3,(H,27,29)(H,30,31)(H2,25,26,32)/t20-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	9.00E+4	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386134 (CHEMBL2042336) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2cccc(F)c2)cc1)C(O)=O |r| Show InChI InChI=1S/C22H21FN4O5/c1-12(2)19(21(29)30)26-20(28)18-11-17(27-32-18)13-6-8-15(9-7-13)24-22(31)25-16-5-3-4-14(23)10-16/h3-12,19H,1-2H3,(H,26,28)(H,29,30)(H2,24,25,31)/t19-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	9.40E+4	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386144 (CHEMBL2042346) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2cc(C)cc(C)c2)cc1)C(O)=O |r| Show InChI InChI=1S/C24H26N4O5/c1-13(2)21(23(30)31)27-22(29)20-12-19(28-33-20)16-5-7-17(8-6-16)25-24(32)26-18-10-14(3)9-15(4)11-18/h5-13,21H,1-4H3,(H,27,29)(H,30,31)(H2,25,26,32)/t21-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1.14E+5	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386151 (CHEMBL2042352) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(Nc2nc3ccc(F)cc3s2)cc1)C(O)=O |r| Show InChI InChI=1S/C22H19FN4O4S/c1-11(2)19(21(29)30)26-20(28)17-10-16(27-31-17)12-3-6-14(7-4-12)24-22-25-15-8-5-13(23)9-18(15)32-22/h3-11,19H,1-2H3,(H,24,25)(H,26,28)(H,29,30)/t19-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	n/a	n/a	1.20E+5	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386123 (CHEMBL2042207) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2ccc(Cl)cc2)cc1)C(O)=O |r| Show InChI InChI=1S/C22H21ClN4O5/c1-12(2)19(21(29)30)26-20(28)18-11-17(27-32-18)13-3-7-15(8-4-13)24-22(31)25-16-9-5-14(23)6-10-16/h3-12,19H,1-2H3,(H,26,28)(H,29,30)(H2,24,25,31)/t19-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1.24E+5	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386141 (CHEMBL2042343) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2cc(F)ccc2F)cc1)C(O)=O |r| Show InChI InChI=1S/C22H20F2N4O5/c1-11(2)19(21(30)31)27-20(29)18-10-16(28-33-18)12-3-6-14(7-4-12)25-22(32)26-17-9-13(23)5-8-15(17)24/h3-11,19H,1-2H3,(H,27,29)(H,30,31)(H2,25,26,32)/t19-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1.41E+5	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386119 (CHEMBL2042335) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2ccccc2F)cc1)C(O)=O |r| Show InChI InChI=1S/C22H21FN4O5/c1-12(2)19(21(29)30)26-20(28)18-11-17(27-32-18)13-7-9-14(10-8-13)24-22(31)25-16-6-4-3-5-15(16)23/h3-12,19H,1-2H3,(H,26,28)(H,29,30)(H2,24,25,31)/t19-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1.41E+5	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386146 (CHEMBL2042348) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2ccc(C)c(F)c2)cc1)C(O)=O |r| Show InChI InChI=1S/C23H23FN4O5/c1-12(2)20(22(30)31)27-21(29)19-11-18(28-33-19)14-5-8-15(9-6-14)25-23(32)26-16-7-4-13(3)17(24)10-16/h4-12,20H,1-3H3,(H,27,29)(H,30,31)(H2,25,26,32)/t20-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1.78E+5	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386142 (CHEMBL2042344) Show SMILES CC(C)[C@H](NC(=O)c1cc(no1)-c1ccc(NC(=O)Nc2c(F)cccc2F)cc1)C(O)=O |r| Show InChI InChI=1S/C22H20F2N4O5/c1-11(2)18(21(30)31)26-20(29)17-10-16(28-33-17)12-6-8-13(9-7-12)25-22(32)27-19-14(23)4-3-5-15(19)24/h3-11,18H,1-2H3,(H,26,29)(H,30,31)(H2,25,27,32)/t18-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	1.85E+5	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386128 (CHEMBL2042216) Show SMILES CC(C)[C@H](NC(=O)c1ncc(o1)-c1ccc(NC(=O)Nc2ccc(Cl)cc2Oc2ccccc2)cc1)C(O)=O |r| Show InChI InChI=1S/C28H25ClN4O6/c1-16(2)24(27(35)36)33-25(34)26-30-15-23(39-26)17-8-11-19(12-9-17)31-28(37)32-21-13-10-18(29)14-22(21)38-20-6-4-3-5-7-20/h3-16,24H,1-2H3,(H,33,34)(H,35,36)(H2,31,32,37)/t24-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	n/a	n/a	2.30E+5	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386150 (CHEMBL2042220) Show SMILES CC(C)[C@H](NC(=O)c1nc(no1)-c1ccc(NC(=O)Nc2ccc(F)cc2F)cc1)C(O)=O |r| Show InChI InChI=1S/C21H19F2N5O5/c1-10(2)16(20(30)31)26-18(29)19-27-17(28-33-19)11-3-6-13(7-4-11)24-21(32)25-15-8-5-12(22)9-14(15)23/h3-10,16H,1-2H3,(H,26,29)(H,30,31)(H2,24,25,32)/t16-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem	Article PubMed	n/a	n/a	2.59E+5	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386121 (CHEMBL2042202) Show SMILES CC(C)[C@H](NC(=O)c1ncc(o1)-c1ccc(NC(=O)Nc2ccccc2Cl)cc1)C(O)=O |r| Show InChI InChI=1S/C22H21ClN4O5/c1-12(2)18(21(29)30)27-19(28)20-24-11-17(32-20)13-7-9-14(10-8-13)25-22(31)26-16-6-4-3-5-15(16)23/h3-12,18H,1-2H3,(H,27,28)(H,29,30)(H2,25,26,31)/t18-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	2.82E+5	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair
Chondroitin sulfate N-acetylgalactosaminyltransferase 1 (Homo sapiens (Human))	BDBM50386125 (CHEMBL2042211) Show SMILES CC(C)[C@H](NC(=O)c1ncc(o1)-c1ccc(NC(=O)Nc2cccc(c2)C(F)(F)F)cc1)C(O)=O |r| Show InChI InChI=1S/C23H21F3N4O5/c1-12(2)18(21(32)33)30-19(31)20-27-11-17(35-20)13-6-8-15(9-7-13)28-22(34)29-16-5-3-4-14(10-16)23(24,25)26/h3-12,18H,1-2H3,(H,30,31)(H,32,33)(H2,28,29,34)/t18-/m0/s1	Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	CHEMBL PC cid PC sid UniChem Similars	Article PubMed	n/a	n/a	4.58E+5	n/a	n/a	n/a	n/a	n/a	n/a
Piramal Healthcare Limited Curated by ChEMBL					Assay Description Inhibition of human DGAT1 assessed as conversion of [14C]-oleoyl-CoA to [14C]-triglyceride after 10 mins by scintillation counting				Eur J Med Chem 54: 324-42 (2012) Article DOI: 10.1016/j.ejmech.2012.05.016 BindingDB Entry DOI: 10.7270/Q25B03HK
					More data for this Ligand-Target Pair